Andere Sprachen Syncona Limited

Aktien

A1J7JP

GG00B8P59C08

BACT

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:02 12.09.2024			% 5 Tage	% 1. Jan.
112,40 ^GBX	-2,77 %		-5,55 %	-8,91 %

13.08.	Syncona-Nettoinventarwert sinkt um 5% aufgrund des Kursrückgangs der Autolus-Aktie	AN
13.08.	Syncona verzeichnet Rückgang des Nettoinventarwerts im ersten Quartal des Geschäftsjahres	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Syncona : Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024	27.08.
Syncona net asset value down 5% reflecting fall in Autolus share price	13.08.
Syncona Logs Decline in Fiscal Q1 Net Asset Value	13.08.
Syncona : Quarterly Update covering the period 01 April 2024 to 30 June 2024	13.08.
Syncona : Results of Annual General Meeting	06.08.
Syncona : Anaveon appoints Dieter Weinand as Chair of its Board of Directors	30.07.
Syncona : Beacon Therapeutics appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer	24.07.
Syncona : Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors	11.07.
Syncona : Spur Therapeutics Completes Enrollment in Phase 1/2 GALILEO-1 Trial of FLT201 in Gaucher Disease and Selects Dose for Planned Phase 3 Trial	10.07.
Syncona : IOnctura announces expansion of roginolisib clinical trial program to NSCLC	09.07.
Thor Energy drilling starts; Deltic accepts licence	08.07.
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies	04.07.
Syncona : Notice of the 2024 Annual General Meeting	03.07.
Syncona Invests Additional $42.5 Million in Beacon Therapeutics	03.07.
Syncona's portfolio Beacon Therapeutics raises USD170 million	03.07.
Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	02.07.
Syncona : Spur Therapeutics Presents Promising New Data from its GBA1 Parkinson’s Disease Research Program	01.07.
Syncona Chair & CEO Hollowood buys GBP100,000 in shares	25.06.
IOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials	21.06.
Syncona : Sustainability Report for the year ended 31 March 2024	20.06.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Syncona Limited

Aktien

A1J7JP

GG00B8P59C08

BACT

Andere Sprachen

Filter